Bundamedik Tbk PT (BMHS) — Capital Reinvestment Ratio
Bundamedik Tbk PT (BMHS) has a Capital Reinvestment Ratio of 0.58x as of December 2025, meaning it reinvests 1% of its operating cash flow (Rp199.64 Billion) in capital expenditures (Rp116.26 Billion). Check tangible equity quality of Bundamedik Tbk PT to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Bundamedik Tbk PT Capital Reinvestment Ratio (2018–2025)
This chart tracks Bundamedik Tbk PT's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see BMHS operating cash flow.
Annual Capital Reinvestment Ratio for Bundamedik Tbk PT (2018–2025)
Year-by-year Capital Reinvestment Ratio for Bundamedik Tbk PT from 2018 to 2025. See free cash flow generation of Bundamedik Tbk PT to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (IDR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.87x | Rp250.62 Billion | Rp218.91 Billion | ▼ -87.4% |
| 2024 | 6.95x | Rp33.98 Billion | Rp236.03 Billion | ▲ +70.7% |
| 2023 | 4.07x | Rp51.44 Billion | Rp209.35 Billion | ▲ +220.3% |
| 2022 | 1.27x | Rp237.47 Billion | Rp301.73 Billion | ▲ +94.7% |
| 2021 | 0.65x | Rp349.44 Billion | Rp228.08 Billion | ▲ +150.5% |
| 2020 | 0.26x | Rp190.36 Billion | Rp49.61 Billion | ▼ -67.8% |
| 2019 | 0.81x | Rp89.72 Billion | Rp72.50 Billion | ▼ -77.4% |
| 2018 | 3.57x | Rp43.79 Billion | Rp156.54 Billion | — |